Market Overview

Influenza Vaccines Market Size Worth USD 7.34 Billion by 2026; Rising Preventive Health Measures Undertaken by Governments Worldwide to Boost the Market: Fortune Business Insights™


Pune, Jan. 03, 2020 (GLOBE NEWSWIRE) -- The global Influenza Vaccine Market size is slated to reach USD 7.34 billion by 2026, exhibiting a CAGR of 7.7% during the forecast period. Increasing prevalence of influenza worldwide will be the major driving force behind the growth of this market. According to the World Health Organization (WHO), around 3 to 5 million cases of influenza-based diseases are reported annually across the globe. This has spurred governments to take proactive measures to contain the spread of this deadly disease. Many governments carry out extensive vaccination drives before the flu season begins to immunize people from contracting any such infections, bolstering the seasonal Influenza Vaccine Market demand. At the global level, organizations such as the WHO and the United Nations' Children Fund (UNICEF) regularly recommend various seasonal and general influenza vaccines to regional public authorities. These factors are expected to give rise to a robust growth period for this market.

According to a new Fortune Business Insights™ report, titled "Influenza Vaccine Market Size, Share & Industry Analysis, By Type (Inactivated, and Live Attenuated), By Valency (Quadrivalent and Trivalent), By Age Group (Pediatric and Adults), By Distribution Channel (Hospital & Retail Pharmacies, Government Suppliers and Others) and Geography Forecast, 2019-2026", the value of this market stood at USD 4.05 billion in 2018. In addition to market value, the report provides the following:

  • An exhaustive research into the different segments to comprehensively understand the market;
  • A careful study of the industry trends that will shape the size, share, and overall growth of the market; and
  • A detailed assessment of the various factors, future prospects, and regional and competitive dynamics influencing the market.

For more information in the analysis of this report, visit:

Initiation of Government-backed Immunization Programs to Foster Greater Demand

Governments all around the world are increasingly focusing on initiating large-scale immunization drives to tackle influenza and related diseases, which is benefiting the flu vaccine market. These initiatives are receiving active support from international organizations such as the WHO. More importantly, these bodies are increasing their surveillance capacities to contain the spread of the disease and taking all measures necessary to prevent the outbreak of an epidemic. Many organizations, such as the Bill and Melinda Gates Foundation, Centers for Disease Control and Prevention (CDC), and WHO Global Influenza Surveillance and Response System (GISRS), are also facilitating research through increased funding for the development of up-to-date vaccines. This is enabling governments to launch broad-based domestic immunization drives, which will play a central role in determining the Influenza Vaccine Market trends during the forecast period.

North America to Occupy a Commanding Position; Asia-Pacific to Register Robust Growth

Having generated a revenue of USD 1.98 billion in 2018, North America is expected to dominate the Influenza Vaccine Market share primarily owing to the utilization of advanced manufacturing systems and processes for vaccines. Besides this, rising incidence of influenza, well-funded vaccine research programs, and presence of big companies will further fuel the market in this region. Asia-Pacific will boast the highest growth rate among regions on account of fast-increasing population along with active government support for healthcare research will raise the demand for effective vaccines in the region. Lastly, increasing immunization rate, coupled with high awareness regarding vaccination, will drive the market in Europe.  

Presence of a Few Players to Make Competition Tight

Through its Influenza Vaccine Market report, Fortune Business Insights™ has brought out an in-depth analysis of the competition in this market. The report states that the competitive landscape will be dotted by a few key players who are increasing their investment in enhancing their R&D capacities to widen their product portfolio.

Request a Sample Copy of the Research Report:

Key Industry Developments:

  • November 2019: Sanofi received clearance for its Fluzone® High-Dose Quadrivalent from the US Food and Drug Administration (FDA). Containing an additional Influenza B strain, the drug is designed and aimed at treating adults at and over the age of 65.

  • January 2019: The European Commission green lit Seqirus's FLUCELVAX® TETRA for marketing in Europe. This is a cell-based quadrivalent influenza vaccine, the first of its kind to be marketed in Europe, which is to be used on people aged 9 years and above.

List of Key Companies Profiled in the Influenza Vaccine Market Research Report are:

  • AstraZeneca
  • F. Hoffmann-La Roche Ltd
  • Sanofi
  • GlaxoSmithKline plc.
  • Sinovac Biotech Ltd
  • CSL Limited
  • Emergent BioSolutions Inc.
  • BioDiem

Have Any Query? Ask Our Experts:

Detailed Table of Content:

  • Introduction
    • Research Scope
    • Market Segmentation
    • Research Methodology
    • Definitions and Assumptions
  • Executive Summary
  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Key Insights
    • New Product Launch
    • Pipeline Analysis
    • Prevalence of Influenza- For Key Countries, 2018
    • Key Industry Developments - Mergers, Acquisitions, and Partnerships
  • Global Influenza Vaccine Market Analysis, Insights and Forecast, 2015-2026
    • Key Findings / Summary
    • Market Analysis, Insights and Forecast – By Type
      • Inactivated
      • Live Attenuated
    • Market Analysis, Insights and Forecast – By Valency
      • Quadrivalent
      • Trivalent
    • Market Analysis, Insights and Forecast – By Age Group
      • Pediatric
      • Adults
    • Market Analysis, Insights and Forecast – By Distribution Channel
      • Hospital & Retail Pharmacies
      • Government Suppliers
      • Others
    • Market Analysis, Insights and Forecast – By Geography
      • North America
      • Europe
      • Asia pacific
      • Latin America
      • Middle East & Africa

TOC Continued….!

Request for Customization:

Have a Look at Related Reports:

Vaccines Market Size, Share & Industry Analysis, By Type (Recombinant/Conjugate/Subunit, Inactivated, Live Attenuated and Toxoid), By Route of Administration (Parenteral and Oral), By Disease Indication (Viral Diseases and Bacterial Diseases), By Age Group (Pediatric and Adults), By Distribution Channel (Hospital & Retail Pharmacies, Government Suppliers and Others) and Region Forecast, 2019-2026

Veterinary/Animal Vaccines Market Size, Share & Industry Analysis, By Product (Inactivated, Live Attenuated, Recombinant, Others), By Animal (Companion, Livestock), By Route of Administration (Oral, Parenteral, Others), By Distribution Channel (Veterinary Hospitals, Veterinary Clinics, Pharmacies & Drug Stores, Others) and Regional Forecast, 2019-2026

Urinary Drainage Bags Market Size, Share & Industry Analysis, By Product (Leg Bags and Large Capacity Bags), By Capacity (0-500 ml, 500-1000 ml, 1000-2000 ml, and more than 2000 ml), By Number of Chambers (Single Chamber, 2 Chamber, 3 Chamber), End-user (Hospitals, Clinics, Ambulatory Surgical Centers, Home Care, and Others), and Regional Forecast 2019-2026

Plasma Fractionation Market Size, Share & Industry Analysis, By Product Type (Albumin, Immunoglobulin (Intravenous Immunoglobulin and Subcutaneous Immunoglobulin), Coagulation Factors, Protease Inhibitors and Others), By Application (Immunology & Neurology, Hematology, Critical Care, Pulmonology and Others), By End User (Hospitals & Clinics,) and Geography Forecast, 2019-2026

Bovine Lactoferrin Market Size, Share Trends & Industry Analysis, By Product (Spray-dried, and Freeze-dried), By Application (Infant Formula, Pharmaceuticals, Dietary Supplements, Food, and Others), and Regional Forecast, 2019-2026

Orthopedic Implants Market Size, Share & Industry Analysis, By Product (Joint Reconstruction; Spinal Implants; Trauma Implants, Dental Implants; Orthobiologics, and Others) End-user (Hospitals, Orthopedic Clinics, Ambulatory Surgical Centers, and Others) and Regional Forecast, 2019-2026

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
| Twitter | Blogs

Press Release:

Primary Logo

View Comments and Join the Discussion!